Drugs / NaCl
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01515397 | Dec 2011 → Jan 2013 | — | B. Braun Melsungen AG | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NaCl | “Gelofusine 4% combined with NaCl 0.9%” NCT01515397 ↗ |